Effect of low molecular weight heparin on intra-abdominal metastasis in a laparoscopic experimental study

International Journal of Colorectal Disease

Volumn 19, Issue 2, 2004, Pages 143-146

  Pross, Matthias ^a   Lippert, H ^a   Nestler, G ^a   Kuhn, R ^a   Langer, H ^a   Mantke, R ^a   Schulz, H U ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Laparoscopy; Low molecular weight heparin; Metastasis; Tumor growth

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN;

ABDOMINAL TUMOR; ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL STRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; LAPAROSCOPY; LIVER METASTASIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TUMOR BIOPSY; TUMOR GROWTH; TUMOR VOLUME;

ABDOMINAL NEOPLASMS; ADENOCARCINOMA; ANIMALS; ANTICOAGULANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPARIN, LOW-MOLECULAR-WEIGHT; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LAPAROSCOPY; PERITONEAL NEOPLASMS; RATS; RATS, WISTAR; TUMOR CELLS, CULTURED;

EID: 1242285585     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-003-0535-7     Document Type: Article

References (22)

1. Neuhaus SJ, Ellis T, Jamieson GG, Watson DI (1999) Experimental study of the effect of intraperitoneal heparin on tumour implantation following laparoscopy. Br J Surg 86:400-404
2. Hermanek P, Wittekind C (1994) Inwieweit sind laparoskopische Verfahren in der onkologischen Chirurgie vertretbar? Chirurg 65:23-28
3. Jacobi CA, Peter FJ, Wenger FA, Ordemann J, Iler JM (1999) New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat. Dig Surg 16:393-399
4. Reymond MA, Schneider C, Kastl S, Hohenberger W, Kockerling F (1998) The pathogenesis of port-site recurrences. J Gastrointest Surg 2:406-414
5. Kockerling F, Reymond MA, Schneider C, Hohenberger W (1997) Fehler und Gefahren in der onkologischen laparoskopischen Chirurgie. Chirurg 68:215-224
6. Lee SW, Gleason NR, Bessler M, Whelan RL (1999) Peritoneal irrigation with povidone-iodine solution after laparoscopic-assisted splenectomy significantly decreases port-tumor recurrence in a murine model. Dis Colon Rectum 42:319-326
7. Pross M, Lippert H, Mantke R, Kruger S, Gunther T, Marusch F, Halangk W, Schulz HU (2001) A proteinase inhibitor decreases tumor growth in a laparoscopic rat model. Surg Endosc 15:882-885
8. Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160
9. Ghadimi BM, Schlag PM (1998) [Tumor metastasis. Molecular principles and therapeutic options]. Chirurg 69:1315-1322
10. Ghadimi BM, Behrens J, Hoffmann I, Haensch W, Birchmeier W, Schlag PM (1999) Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer 35:60-65
11. Hejna M, Raderer M, Zielinski CC (1999) Inhibition of metastases by anti-coagulants. J Natl Cancer Inst 91:22-36
12. Jacobi CA, Ordemann J, Bohm B, Zieren HU, Sabat R, Muller JM (1997) Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. Am J Surg 174:359-363
13. Columbus Investigators (1997) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337:657-662
14. Prandoni P, Lensing AW, Buller HR, Carta M, Cogo A, Vigo M, Casara D, Ruol A, ten Cate JW (1992) Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 339:441-445
15. Jacobi CA, Peter FJ, Wenger FA, Ordemann J, Muller JM (1999) New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat. Dig Surg 16:393-399
16. Tempelhoff GF von, Harenberg J, Niemann F, Hommel G, Kirkpatrick CJ, Heilmann L (2000) Effect of low molecular weight heparin (certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: a prospective randomized double-blind trial. Int J Oncol 16:815-824
17. Martin MS, Martin F, Michiels R, Bastien H, Justrabo E, Bordes M, Viry B (1973) An experimental model for cancer of the colon and rectum. Intestinal carcinoma induced in the rat 1:2-dimethylhydrazine. Digestion 8:22-34
18. Zöller M, Matzku S (1999) Tumorprogression: Adhäsion, Proteolyse und Angiogenese. Chir Gastroenterol 15:128-136
19. See WA, Chapman PH (1987) Heparin prevention of tumor cell adherence and implantation on injured urothelial surfaces. J Urol 138:182-186
20. See WA (1993) Plasminogen activators: regulators of tumor cell adherence to sites of lower urinary tract surgical trauma. J Urol 150:1024-1029
21. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der MJ, Gallus AS, Simonneau G, Chesterman CH, Prins MH (1996) Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 334:682-687
22. Pearlstone DB, Feig BW, Mansfield PF (1999) Port site recurrences after laparoscopy for malignant disease. Semin Surg Oncol 16:307-312